These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38286026)

  • 21. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics.
    Tajdini F; Amini MA; Mokarram AR; Taghizadeh M; Azimi SM
    Pharm Dev Technol; 2014 May; 19(3):333-41. PubMed ID: 23590209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
    Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
    Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines.
    Robinson L; Knight-Jones TJ; Charleston B; Rodriguez LL; Gay CG; Sumption KJ; Vosloo W
    Transbound Emerg Dis; 2016 Jun; 63 Suppl 1():30-41. PubMed ID: 27320164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate.
    Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y
    J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasonic Preparation of Nano-CaCO
    Liu X; Wu Z; Cavalli R; Manzoli M; Cravotto G
    AAPS PharmSciTech; 2024 Jul; 25(6):165. PubMed ID: 39009915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticulate chitosan-TNF-α-VLPs activate mast cells and enhance adaptive immunity induced by foot-and-mouth disease virus-like particles in mice.
    Bai R; Li M; Tian Z; Hu Y; An M; Yuan W; Li L
    Vet Immunol Immunopathol; 2023 Oct; 264():110662. PubMed ID: 37862872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyethylenimine Hybrid Thin-Shell Hollow Mesoporous Silica Nanoparticles as Vaccine Self-Adjuvants for Cancer Immunotherapy.
    Liu Q; Zhou Y; Li M; Zhao L; Ren J; Li D; Tan Z; Wang K; Li H; Hussain M; Zhang L; Shen G; Zhu J; Tao J
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47798-47809. PubMed ID: 31773941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemokine CCL20 plasmid improves protective efficacy of the Montanide ISA™ 206 adjuvanted foot-and-mouth disease vaccine in mice model.
    Jayeshbhai C; Hajam IA; Verma AK; Bhanuprakash V; Kondabattula G; Kishore S
    Vaccine; 2018 Aug; 36(35):5318-5324. PubMed ID: 30054161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a hollow mesoporous silica nanoparticles vaccine to protect against house dust mite induced allergic inflammation.
    Peng X; Liang Y; Yin Y; Liao H; Li L
    Int J Pharm; 2018 Oct; 549(1-2):115-123. PubMed ID: 30040973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hollow Mesoporous Silica Nanoparticles with Tunable Structures for Controlled Drug Delivery.
    Li Y; Li N; Pan W; Yu Z; Yang L; Tang B
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2123-2129. PubMed ID: 28004570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced immunogenicity of foot and mouth disease DNA vaccine delivered by PLGA nanoparticles combined with cytokine adjuvants.
    Yang Y; Teng Z; Lu Y; Luo X; Mu S; Ru J; Zhao X; Guo H; Ran X; Wen X; Sun S
    Res Vet Sci; 2021 May; 136():89-96. PubMed ID: 33592449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved Gene Transfer with Functionalized Hollow Mesoporous Silica Nanoparticles of Reduced Cytotoxicity.
    Zhan Z; Zhang X; Huang J; Huang Y; Huang Z; Pan X; Quan G; Liu H; Wang L; Wu AC
    Materials (Basel); 2017 Jun; 10(7):. PubMed ID: 28773087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle.
    Xiao Y; Chen HY; Wang Y; Yin B; Lv C; Mo X; Yan H; Xuan Y; Huang Y; Pang W; Li X; Yuan YA; Tian K
    BMC Biotechnol; 2016 Jul; 16(1):56. PubMed ID: 27371162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvants for foot-and-mouth disease virus vaccines: recent progress.
    Cao Y
    Expert Rev Vaccines; 2014 Nov; 13(11):1377-85. PubMed ID: 25234962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.